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Abstract. The mechanisms that generate the intercel-
lular heterogeneity of functional and proliferation re-
sponses in a tissue are generally unknown. In the thy-
roid gland, this heterogeneity is peculiarly marked and
it has been proposed that it could result from the co-
existence of genetically different subpopulations of
thyrocytes. To evaluate the heterogeneity of prolifera-
tive responses in primary culture of dog thyrocytes,
we asked whether the progeny of cells having incorpo-
rated 1H thymidine in a first period ofthe culture could
have a distinct proliferative fate during a second label-
ing period (incorporation of bromodeoxyuridine re-
vealed by immunofluorescence staining combined with
autoradiography of 3H thymidine). No growth-prone
subpopulations were detected and the great majority of
cells were found to response to either EGF or thyro-
tropin (TSH) through cAMP. However, only a fraction
of cells replicated DNA at one given period and a clus-
tered distribution of labeled cells within the monolayer,
which was different for thymidine- or bromodeoxyuri-
dine-labeled cells, indicates some local and temporal
NDIVIDUALcells inatissue maydisplay differentproper-
ties, inrelation to theirdifferentiationstage (coexistence
ofstem cells, transit cells, and terminally differentiated
cells of a given lineage (Hall and Watt, 1989; Potten and
Loeffler, 1990)), orbecause ofadifferentmicroenvironment
(influencedby microvascularization, innervation, cellular in-
teractions through cell adhesion molecules, substrate adhe-
sion molecules, extracellular matrix or paracrine and auto-
crine factors). A striking heterogeneity may arise even
among cells derived from a same clone in tissue culture.
Thus, marked differences in multiplication rates or growth
factor sensitivity are observed at high frequency even be-
tweensister cellsin normal humanfibroblastsorin immortal
3T3 cell lines (Smith and Whitney, 1980; Brooks et al.,
1984; Grundel and Rubin, 1988). Heterogeneity increases
during aging in vivo and during senescence in tissue culture
as exemplified by a progressivedecrease ofthe proliferative
fraction in cells with finite life span (Hayflick, 1977; Smith
andWhitney, 1980; Matsumura, 1984). Intercellularhetero-
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synchrony of neighboring cells.
The TSH/cAMP-dependent division of thyrocytes
preserved their responsiveness to both TSH and EGF
mitogenic pathways. By contrast, cells that had
divided during a momentary treatment with EGF lost
the mitogenic sensitivity to TSH and cAMP (forskolin)
but retained the sensitivity to EGR Since cells that
had not divided kept responsiveness to both TSH and
EGF, this generated two subpopulations differing in
mitogen responsiveness. The extinction of the TSH/
cAMP-dependent mitogenic pathway was delayed
(1-2 d) but stable. Cell fusion experiments suggest it
was due to the induction of a diffusible intracellular
inhibitor ofthe cAMP-dependent growth pathway.
These findings provide a useful model of the genera-
tion of a qualitative heterogeneity in the cell sensitiv-
ity to various mitogens, which presents analogies with
other epigenetic processes, such as differentiation and
senescence. They shed a new light on the significance
of the coexistence of different modes of cell cycle con-
trols in thyroid epithelial cells.
geneityisalsoone ofthestriking featuresoftissue pathology,
mostly in diseases involving cell multiplication processes.
Thisistrueevenwhena single cause isinvolved. An interest-
ing example of such tissue heterogeneity in disease is pro-
vided by thyroid goiter, whether due to a single genetic de-
fect (e.g., iodide oxidation), nutritional deficiency (iodine),
or abnormal stimulation (thyroid stimulating antibodies)
(Ingbar and Braverman, 1986).
A central question is thus whetherheterogeneity ofcellu-
lar responses results from stochastic intracellular factors,
changes in cell microenvironment, coexistence of geneti-
callydifferentsubpopulations, or onthe acquisition ofstable
shifts in phenotypic expression. Primary cultures of un-
selected cells allow the study of cells representative of in
vivo situationsundercontrolled conditions. However,inbio-
chemical studies, these cells are generally investigated as a
whole presumably homogeneous population. The great
majority of unselected cells that constitute the primary cul-
tures ofepithelial dog thyroid cells (thyrocytes), shareboth
383the capacity to proliferate (Roger et al., 1987a) and to ex-
press thyroid differentiation (Pohl et al., 1990). However, the
rates of differentiation expression (stimulated by thyrotropin
[TSH]) present a high intercellular variability (Pohl et al.,
1990) and the general proliferative response is dependent on
a very strong stimulation by a combination of mitogens act-
ing through quite different mechanisms. When thyrocytes are
stimulated by their physiological signal, TSH acting through
cAMP, or by other cAMP-independent mitogens such as
EGF, phorbol esters, and serum, each added separately, the
limited increase in the thymidine-labeling index (Roger et
al., 1987a) suggests that the proliferative fraction could be
markedly inferior to 1, as shown in 3T3 fibroblasts stimu-
lated by suboptimal serum concentrations (Brooks et al.,
1984; Brooks and Riddle, 1988) . These data, together with
a qualitative intercellular difference in cytoskeleton compo-
sition (presence or not of vimentin beside cytokeratin)
(Coclet et al., 1991), are indicative of a considerable inter-
cellular heterogeneity, which might reflect the well-known in
vivo heterogeneity of growth and function responses in thy-
roid gland (Dumont, 1971; Studer et al., 1989) .
In this study, usinga method of double labeling to demon-
strate DNA synthesis at different periods of the culture, we
assess the heterogeneity of proliferative responses of these
cultured dog thyrocytes. We show that the great majority of
these cells share the capacity of proliferating in response to
either TSH or EGF, though the mitogenic responses need
several days before concerningthe whole cell population. On
the other hand, we report evidence that a specific inhibitor(s)
of the TSH/CAMP-dependent mitogenic pathway is lately in-
duced in the fraction of cells that have divided during a
momentary treatment with cAMP-independent mitogens
(EGF, serum). This inhibitory factor(s) is trans-dominant in
cell fusion experiments. By contrast, the cAMP-dependent
division of thyrocytes preserves their susceptibility to both
cAMP-dependent and independent mitogenic pathways.
These unexpected findings provide a useful model of the
generation of a stable qualitative heterogeneity, presumably
epigenetic, in the cell sensitivity to various mitogens.
Materials and Methods
Primary Cultures ofDogThyroidFollicularCells
The cells were obtained from dog thyroid as detailed previously (Roger
et al., 1982). Briefly, the tissue was digested by collagenase (type I; Wor-
thington Biochemical Corp., Freehold, NJ) so that the resulting suspension
consisted mainly of frag 2mented and intact follicles. These follicles were
seeded (±2.104 cells/cm) in 35-mm tissue culture-treated petri dishes; the
follicles attached with a high yield (±75%) and developed in 1-2 d as a
monolayer. The cells were cultured inthe followingmixture that constitutes
the control medium (Roger and Dumont, 1984;. Roger et al., 1987a):
DMEM + Ham'sF12 medium + MCDB104 medium (Gibco Laboratories,
Paisley, UK) (2:1:1 by vol) with 1 mM sodium pyruvate, supplementedwith
ascorbic acid (40 pg/ml), insulin (5 mg/ml) (Sigma Chemical Co, St Louis,
MO), 1% FBS (Sera-Lab, Sussex, UK), antibiotics (100 U penicillin/ml,
100 ug streptomycin/nil, 2.5 hg amphotericin B/ml). The cells were kept
in a water-saturated incubator at 37°C in an atmosphere of5% C02 in air.
The medium was renewed every other day or every day when cells ap-
proached confluency.
As indicatedinthe Results, thyrocytes in primary culture weresubmitted
to various additions: bovine TSH (Sigma Chemical Co.), murine EGF
(Sigma Chemical Co.), forskolin (Calbiochem-Behring Corp., La Jolla,
CA) and 10% FBS.
1. Abbreviations used in this paper: BUDR, 8-bromo-deoxycytdine; TSH,
thyrotropin.
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As discussed earlier (Roger and Dumont, 1984) and assessed recently
by thyroglobulin mRNA in situ hybridization (Pohl et al., 1990) and
cytokeratin immunofluorescence (Coclet et al., 1991), the cultures consist
of >98% thyrocytes.
The cell DNA assay described previously (Roger et al., 1982) uses the
increaseof fluorescence ofethidium bromide when complexed with nucleic
acids.
Double Labeling ofDNA Synthesis
As indicated in the Results, cells were incubated for a first 24-h labeling
period in the complete medium containing 3 x 10-5 M thymidine, 10-4 M
deoxycytidine, and 10 WCi/ml 3H thymidine (Amersham International,
Amersham, UK). It was verified that these conditions of 3H thymidine in-
cubation did not affect the subsequent proliferation ofthyrocytes, in growth
curves obtained with or without 3H thymidine (not shown). After two
washings ofthe cells, cultures werecontinued as indicated andthe cells were
then incubated for a second 24-h labeling period in the complete medium
containing 10-4 M 8-bromo-deoxycytdine (BUDR) (Sigma Chemical Co.)
and 2 x 10-6 M fluorodeoxycytidine. Cells in the petri dishes were fixed
in methanol for 10 min at -20°C, and kept in pH 7.5, PBS.
Cells were permeabilized with Triton X100 (0.15%) for 10 min at room
temperature, incubated with 2 N HCl for 30 min (roomtemperature), then
rinsed and incubated for 10 min in a borax buffer (0.1 M Na2B407, pH
8.5). Subsequent rinses were followed by addition, for 30 min, of normal
sheep serum (1/20 in PBS with 0.1% BSA). The cells were then incubated
overnight at 4°C in PBS/BSA with the antibromodeoxyuridine mAb (1/50,
Becton Dickinson), together with a polyclonal rabbit broad-spectrum an-
ticytokeratin antibody (1/50, Dakopatts Z622). Then cells were washed and
successively incubated for 1 h at room temperature with biotinylated sheep
anti-mouseIgs (1/50 RPN1001 from AmershamInternational) together with
Texas red-conjugated donkey anti-rabbit Igs (1/50, N2034 from Amersham
International) and then with fluorescein-streptavidin (1/30, RPN1232 from
Amersham International).
The cells were finallyprocessed for autoradiography (one week exposure
at4°C using 1:1 diluted Ilford K5 emulsion); counterstained withpropidium
iodide (0.5 pg/ml for 3 min); and mounted in Gelvatol (polyvinylalcohol,
Monsanto) solution(20g Gelvatol + 80 nil PBS + 40ml glycerol) contain-
ing 100 mg/ml 1,4 diazobicyclo(2,2,2) octane to delay the fluorescence
fading.
Cells were viewed with a Leitz epifluorescence microscope (50x oil im-
mersion lens; L2,12, and N3 fluorescence filter blocks), and the proportion
ofcytokeratin-positivecellsthat are labeledwith thymidine, BUDR, orboth
was determined by counting 500-1,000 cells per dish. Microphotographs
were taken using 400 iso Fujichrome films.
CellFusion Experiments
Thyroid follicles were seeded in control medium in 90-mm tissue cul-
ture-treated petri dishes and submitted 1 d later to EGF (25 ng/ml) or TSH
(1 mU/ml) for 3 d, with 3H thymidine during the last 24 h. After rinsing,
the cells were cultured for two additional days in control medium and
detached from the dishes with a trypsin/EDTA solution. Cells from two
dishes were pooled in a 12-ml polystyrene conical centrifuge tube. After
centrifugation, the cell pellet was rinsed with culture medium with 1% se-
rum and one more time with serum-free medium. The last pellet was ob-
tained by centrifuging cells for 1 min at 1,000 rpm. It was then gently
resuspended in 0.7 ml ofa sterile (0.22 um filtered) solution ofpolyethylene
glycol 4000 (Hipure grade, Koch-Light, Haverhill, UK) made 50% wt/vol
in serum-free medium, by rollingthe tube for90s. The cell suspension was
progressively diluted by successively adding at 60-s intervals 0.7, 1.4, 2.8,
and 5.6 ml of serum-free medium. Between each addition, the cell suspen-
sion was made homogeneous by gently rolling the centrifuge tube. Cells
werecentrifuged, resuspended in 10 ml control medium, and seeded in nine
35-mm culture dishes. One day after, fused cells weretreated by TSH, EGF
or control medium for40 h withBUDR forthelast 24h, and fixed withmeth-
anol. The cells were then processed for double labeling of DNA synthesis
as above. The cell survival was -50% and the yield ofcell fusion, -20%.
BUDR incorporation was analyzed in each sort of dikaryons (with two
thymidine-labeled nuclei, one thymidine-labeled nucleus, or two unlabeled
nuclei) and compared to unfused cells.
DNA Synthesisin Dog ThyroidIn Vivo
Dogs (male, 12-mo-old) received, by oral administration for 4 wk,
384methimazole (2 x 60 mg/d) and propylthiouracil (2 x 150 mg/d) to in-
crease the circulating TSH level. 1 h before thyroid resection, treated and
control animals received 50 mg/hg BUDR by intravenous injection. Im-
munohistochemistry of the BUDR labeling was performed as described
(Coclet et al., 1989).
Results
Proliferative Capacity ofDog ThyroidCells
The proliferative curves obtained in dog thyroid cell primary
cultures initiated from a high yield preparation ofthyroid fol-
licles are shown on Fig. 1. As previously shown (Roger and
Dumont, 1984), a weak proliferation occurred in control
condition only during the first 4 d. It is due to the presence
of insulin and 1% FCS (Roger et al., 1987a). TSH and EGF
at optimal concentrations potently stimulated the prolifera-
tion. The fraction of DNA replicating cells (1-h incubation
with 111 thymidine) was 10% at day 5 in primary culture
of dog thyrocytes continuously stimulated with TSH (1 mU/
ml). This figure was quite similar to the rate of DNA syn-
thesis obtained in vivo in the follicular cells of the thyroid
gland ofdogs treated with methimazole and propylthiouracil
in order to chronically elevate the endogenous TSH levels:
the BUDR-labeling index of thyrocytes was 8.1% in treated
dogs, versus 0.17% in control animals.
Even in the presence of the potent mitogenic combination
of TSH and EGF, proliferation (and DNA synthetic activity,
data not shown) ofcultured thyrocytes stopped after the first
subcultivation, well before confluency was reached (Fig. 1) .
A maximum of four to six population doublings was ob-
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tained in different experiments. Whether this limitation was
due to the exhaustion of an intrinsically limited proliferation
capacity or to a deficiency ofthe culture system is not known.
However, it corresponds to the calculated number of cell
population renewals in the thyroid gland during adult life in
several species, including dogs (Coclet et al., 1989) .
The ProliferativeResponseofThyroid Cellsto TSH
andEGFIs GeneralbutSpread overSeveralDays
Previous studies based on labeling of cells during 24-48 h
incubations with 3H thymidine have suggested that only a
fraction of cells participate to a proliferation response to
TSH or EGF, even when used at optimal concentrations
(Roger et al., 1987a) . Our aim has thus been to define
whether all the cells could participate to the growth re-
sponses shown in Fig. 1, but at different stages ofthe culture,
or whether the proliferation curves could be due to succes-
sive divisions in a rapidly proliferating subpopulation. The
second possibility would imply the existence in the thyroid
of fractions of cells with a higher propensity to proliferate
or to respond to the mitogenic stimuli provided by TSH or
EGF and that these properties would be retained in the prog-
eny of such cells.
To discriminate between both possibilities, we asked
whether the progeny of cells that had incorporated 3H
thymidine in a first period of the culture, had more chance
to synthesize DNA in a second period. This second labeling
was achieved by the incubation of cells with the thymidine
analogue BUDR, the nuclear incorporation of which was re-
vealedby indirect immunofluorescence staining with fluores-
Figure 1. Proliferation of dog thy-
rocytes. Cells were seeded in
control medium. At day 1, TSH
(1 mU/ml), EGF (25 ng/ml), or
both were added to some culture
dishes and their presence was
maintained for the rest of the
culture. At day 10 (arrowhead),
some EGF + TSH-treated cells
were detached by trypsin/EDTA
and re-seeded at 10-fold dilution.
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385Figure 2 . Effect of various TSH concentrations on the fraction of
dog thyrocytes that replicated DNA at day 4 or at day 8 of the cul-
ture. Cells were seeded in control medium (C) and continuously
cultured in the presence of different TSH concentrations after day
1 . They were incubated with 3H thymidine between day 3 and 4
(some cells were fixed and autoradiographed at this stage), and with
BUDR between day 7 and 8. Comparison at day 8 ofthe incorpora-
tion ofBUDR in: (a) cells which had not incorporated 3H thymi-
dine between day 3 and 4 . (b) progeny of cells which had incorpo-
rated 3H thymidine between day 3 and 4 .
cein . The procedure thus utilizes the frequently ignored pos-
sibility of simultaneous observation of immunofluorescence
staining and autoradiographic labeling . The indirect immu-
nofluorescence staining of cytoplasmic cytokeratins with
Texas red was joined as a third label in order to visualize
morphology and ascertain the epithelial nature of the cells .
Nuclear DNA was counterstained with propidium iodide
(red fluorescence) .
Primary cultured thyroid cells were maintained for 8 d ei-
ther in the control conditions, or in the continuous presence
ofdifferentTSH concentrations . They were incubated for 24
h with 3H thymidine between day 3 and 4 (some cells were
fixed and subjected to autoradiography at this stage) and for
24 h with BUDR between day 7 and 8. Increasing TSH con-
centrations produced a gradual increase in the fraction of
cells synthesizing DNA at a given time of the culture (Fig .
2) . It has been claimed that this reflects the presence in the
normal thyroid follicular epithelium of subpopulations of
cells with different hereditary growth propensities (Studer et
al ., 1989) . On the contrary, Fig . 2 shows that cells that had
proliferated in response to low concentrations ofTSH (and
thus could be more sensitive to TSH) were not able to pass
this characteristic to their progeny. Indeed, during continu-
ous stimulation with suboptimal TSH concentrations, the
proliferative activity (at days 7-8) in the progeny ofcells that
had replicated DNA at days 3-4 was always lower than in
their parent cells or than in cells that had not replicatedDNA
in the first labeling period (Fig. 2) . This shows no indication
of the existence of growth-prone subpopulations, but on the
contrary a relative desensitization of the growth response .
Especially in the case of stimulations with suboptimal
TSH concentrations, cells that proliferated at a given time
were unevenly dispersed in the cell monolayer. In a same cul-
ture dish, zones with high proliferative activity were ob-
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Figure 3 . Distribution of cells that had replicated DNA at day
4 (24-h 3H thymidine labeling) or at day 8 (24-h BUDR labeling)
in response to a continuous treatment with a suboptimalTSH con-
centration (0.3 mU/ml) applied at day 1 . Both epifluorescence mi-
crographs were taken from two adjacent fields of the same culture
dish with cells fixed at day 8 and then treated forBUDR immuno-
fluorescence staining (yellow-green fluorescence of nuclei) and au-
toradiography (silver grains on 3H thymidine labeled nuclei) . Pro-
pidium iodide counterstaining (red fluorescence) . BUDR-labeled
and thymidine-labeled cells occurred in clusters that poorly over-
lapped .
served neighboring zones with very few DNA synthesizing
cells . As exemplified in Fig. 3, the zones with high prolifera-
tive activity at days 7-8 were frequently different from the
zones with high proliferative activity at days 3-4 . This indi-
cates that some previously quiescent groups of cells later be-
came highly responsive to low mitogenic concentrations of
TSH, while other groups with high DNA replicating activity
became proliferatively silent . These alternating groups of
resting and dividing cells, which formed a striking patchy
distribution within the cell monolayer, suggest some spatial
and temporal coordination of neighboring cells. However, a
greater overlap of cells replicating DNA at day 4 and at day
8 was observed in cultures subjected to maximal concentra-
tions of mitogens, which induce DNA replication in larger
fractions of the cells population (Fig. 2) .
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In other experiments, thyrocytes were continuously stimu-
lated with maximal concentrations of either TSH or EGF
(Fig. 4). The 36% of TSH-treated cells that had not repli-
cated DNA in the first labeling period were able to respond
later. Indeed, many (56%) of them synthesized DNA during
the second labeling period (Fig. 4). Thus, by combining the
labeling indices obtained for both culture periods, it is con-
cluded that at least 84% of cells (64 + 36 * 0.56) are able
to proliferate in the presence of TSH (Fig. 4). Similarly, a
total of 64% of EGF-treated cells (46 + 54 * 0.33) (Fig. 4)
were seen to proliferate either at days 3-4 or at days 7-8. By
comparison, only 17% of control cells replicated DNA,
mostly during the first labeling period. The values of Fig. 4
should represent only a minimal evaluation of the fraction of
cells that can proliferate in response to TSH or EGF . Many
cells also proliferate during the three days between both
labeling periods (see Fig. 8 for other choices of labeling win-
dows). In fact, when EGF-labeled cells were continuously
incubated with 3H thymidine between day 3 and day 6, 93
of cells were labeled, and 49% of the very few thymidine-
unlabeled cells still incorporated BUDR during an additional
24-h labeling period. Therefore, the great majority of dog
thyrocytes were able to proliferate in response to either TSH
or EGF.
Again, in the case of growth stimulation by either TSH or
EGF, the progeny of cells that had replicated DNA during
the first labeling period presented a weaker DNA replication
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4'.7(33-3)
01 1.
response at the end of the culture, as compared to cells that
had not incorporated thymidine (Fig. 4). Clearly, the frac-
tion of cells that proliferated during the first labeling period
in response to TSH or EGF did not give rise to a progeny
with higher susceptibility to these mitogens. On the con-
trary, their reduced proliferation at late stages of the culture
might reflect a relative desensitization ofthe growth response
or, as suggested by Fig. l, a partial exhaustion of an intrinsi-
cally limited potential of divisions.
Suppression ofcAMRdependentMitogenesisafter
Division inResponse tocAMRindependentStimuli
In a second set of experiments, we assessed whether the sen-
sitivity of a cell progeny to various mitogenic stimuli could
have been modified depending on which mitogenic treatment
had triggered the division of its parent cell. As shown in Fig.
5, cells that did not incorporate thymidine during the first
part ofthe culture, either in control conditions or in response
to EGF or TSH (or forskolin, the general adenylate cyclase
activator that mimics the TSH mitogenic action [Roger et al.,
19ß7b]), were however quite responsive to TSH or EGF,
which produced additive mitogenic effects during the second
part of the culture. Similarly, the progeny of cells that had
incorporated thymidine in response to TSH (or forskolin, not
shown) during the first part ofthe culture, retainedthe capac-
ity to respond to TSH (forskolin) and EGF applied at day 6
387
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Figure 4. Combining DNA
synthesis labeling indices of
thyrocytes from two different
labeling periods reveals that
the majority of thyrocytes can
proliferatein response tomax-
imal concentrations of either
TSH (1 mU/ml) or EGF (25
ng/ml) . Afterday 1, cells were
continuously stimulated with
either TSH or EGF. They
were incubated with 3H thy-
midine between day 3 and 4,
and with BUDR between day
7 and 8. Cellswere fixedat day
4 or 8 and processed for dou-
ble labeling ofDNA synthesis
as described in Materials and
Methods. Values are the frac-
tion (%) of labeled cells (n*)
as they were counted. Values
in brackets are the fraction
(%) of cells undergoing DNA
synthesis (ns) during the 24-h
labeling period. ns is calcu-
lated by the formula
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Figure S. DNA synthesis responses of thyrocytes that had divided
in the presence of different mitogenic pretreatments. After day 1,
cells were cultured until day 6, with a 24-h incubation with 3H thy-
midine between day 3 and 4, in (A) control medium; (B) EGF (25
ng/ml) ; or (C) TSH (1 mU/ml). At day 6, cells were rinsed and
stimulated for 2 additional days as indicated on the figure with
BUDR for the last 24 h. C, control; E, EGF (25 ng/ml); T, TSH
(1 mU/ml); ET, EGF + TSH; F, forskolin (10-5 M). The fraction
of cells incorporating BUDR was determined at day 8 in the total
cell population (a); in the progeny of cells that had incorporated
3H thymidine at day 4 (b); and in the cells that had not incorpo-
rated 3H thymidine at day 4 (c). Results are the mean + SD of
data from independentexperiments (n is the numberofexperiments
for each condition) .
of the culture (Fig. 5 C). By contrast, the progeny of cells
that had incorporated thymidine at days 3-4 in control condi-
tions (Fig. 5 A) or in response to EGF (Fig. 5 B) (or 10%
serum, data not shown) presented a quite altered pattern of
mitogenic responses. A marked, though somewhat reduced
(as shown in Fig. 4), proliferative response to EGF was
retained, but the mitogenic response to TSH or forskolin
(alone, or in addition to EGF) was abolished (Fig. 5) . Since
it has been shown that originally the great majority of cells
do have the capacity to respond to either EGF or TSH (Fig.
4), this implies that the mitogenic sensitivity to TSH and
cAMP has been specifically suppressed in response to cell
division supported by CAMP-independent mitogenic treat-
ments (control [insulin + 1% serum], EGF or serum; but
not TSH). This quite unexpected result was consistently
reproduced in all the experiments performed (Fig. 5) . The
inhibition appeared stable: even a 4-d treatment with forsko-
lin applied at day 6 did not restore the cAMP-dependent
proliferation response in the progeny of cells that had divided
in response to EGF (data not shown) .
This phenomenon thus generates two subpopulations in
dog thyroid cell cultures. As illustrated in Fig. 6, after mito-
genic pretreatment with EGF in the presence of 3H thymi-
dine, thymidine-unlabeled cells frequently incorporated the
BUDR label after TSH stimulation, whereas thymidine-
labeled cells failed to respond to the mitogenic stimulus of
TSH. The thymidine-labeled cells were not completely in-
sensitive to TSH, which induced, in these cells as in
thymidine-unlabeled cells, the same morphological response
associated with a cytokeratin redistribution (Fig. 6 C). By
comparison, in the converse situation, after a mitogenic
pretreatment with TSH in the presence of 3H thymidine,
cells frequently incorporated BUDR after EGF stimulation,
regardless of whether they were labeled with thymidine or
not (Fig. 7).
The Suppression oftheCAMP-dependent Mitogenesis
Isa DelayedPhenomenon Which Does NotDepend
on a Continuous Stimulation with
cAMPRindependentMitogens
In the previous experiments, the suppression of the cAMP-
dependent mitogenic stimulation was observed in the prog-
eny of cells that had incorporated thymidine at day 4 in the
presence of EGF which was maintained for two additional
days before the addition of TSH. During this 2-d period, both
3H thymidine-labeled and -unlabeled cells could have pro-
liferated, and it was not clear why they were so different in
their mitogenic sensitivity to TSH. The apparent paradox is
explainedby the experimentillustrated in Fig. 8. After incor-
poration of thymidine in the presence of EGF, cells were ei-
ther immediately stimulated by TSH (or EGF), or placed in
control medium (which strongly reduces the proliferative ac-
tivity) for one to three days before addition ofTSH (or EGF) .
As shown in Fig. 8, thymidine-labeled cells were insensitive
to the mitogenic action of TSH when TSH was added 2 or
3 d after the 3H thymidine incubation. However, when TSH
was added immediately after the thymidine incubation, an
importantmitogenic response was still observed in these thy-
midine-labeled cells (Fig. 8 A) . This experiment suggests
that the suppression of the TSH-dependent mitogenesis after
proliferation of cells in the presence of EGF concerns only
those cells that have replicated DNA at least 1-2 d before
TSH addition. The 2-d period between 3H thymidine expo-
sure and TSH addition (as in the protocol of Figs. 5 and 6)
is thus necessary to observe the full inhibition of the TSH-
388Figure 6. Suppression ofthe mitogenic response toTSH in the frac-
tion of thyrocytes that had divided in the presence of EGR After
day 1, cells were cultured until day 6 in the presence of EGF (25
ng/ml) (with 3H thymidine between day 3 and 4), and then stimu-
lated byTSH (1 mU/ml) until day 8 (with BUDR for the last 24 h) .
A-C weretaken from the same microscope field . (A)BUDR immu-
nostaining with fluorescein (yellow nuclei) . Red counterstaining of
DNA with propidium iodide . (B) Brightfield micrographs showing
the silver grains of autoradiography on 3H thymidine-labeled nu-
clei . (C) Cytokeratin immunostaining with Texas red . Red staining
ofnuclei with propidium iodide. Note thattheBUDR incorporation
in response to TSH was exclusively restricted to 3H thymidine-
unlabeled cells (A and B) . By contrast, note the homogeneous mor-
phological response of cells to TSH (C) .
dependent proliferation in 3H thymidine-labeled cells . How-
ever, the continuous presence ofEGF and thus proliferation
of cells during this 2-d period is not necessary. This experi-
ment shows that the suppression ofthe cAMP-dependent mi-
togenic stimulation is a delayed phenomenon, the completion
of which requires 1 or 2 d after its commitment during the
execution of cell cycle in the presence of EGF.
By contrast, theDNA synthesis response toEGF remained
elevated throughout the experiment (Fig . 8) . Noteworthy, its
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Figure 7 . Successive mitogenic responses ofthyrocytes toTSH and
EGF. After day 1, cells were cultured until day 6 in the presence
of TSH (1 mU/ml) (with 3H thymidine between day 3 and 4), and
then stimulated byEGF (25 ng/ml) until day 8 (withBUDR for the
last 24-h) . A-C were taken from the same microscope field . (A)
BUDR immunostaining with fluorescein . Propidium iodide coun-
terstaining . (B) Autoradiographical silver grains of 3H thymidine-
labeled nuclei . (C) Cytokeratin immunostaining with Texas red.
Propidium iodide staining of nuclei . Note the high frequency of
BUDR/ 3H thymidine double-labeled cells (shown by white marks
inA) demonstrating the mitogenicresponse toEGF in cells that had
divided in response to TSH . Also note the morphological response
to EGF (C) with elongated cells .
partial desensitization in 3H thymidine cells (which is in ac-
cordance with Figs . 4 and 5) also was delayed .
The Suppression ofthecAMRdependent
Mitogenesis Is a 7)ans-dominantPhenomenon
in Cell Fusion Experiments
The suppression of the cAMP-dependent mitogenesis could
conceivably be caused either by the induction ofintracellular
factor(s) that inhibit the cAMP-dependent mitogenic path-
way (but not the CAMP-independent one), or by the disap-
pearance offactor(s) that wouldbe specifically necessary for
389Figure 8. Kinetics of disap-
pearance of the responsive-
ness tothe mitogenic action of
TSH after division of thyro-
cytes in the presence of EGF.
After day 1, cells were cul-
tured in the presence of EGF
(25 ng/ml) until day 4, with
3H thymidine between day
3 and 4. After day 4, cells
were rinsed andplaced in con-
trol medium for the time (0, 1,
2, or 3 d) indicated on the
abscissa, before being treated
for two additional days, with BUDR for the last 24 h, with control
medium (o), EGF (25 ng/ml) (e), or TSH (1 mU/ml) (o). The
fraction of cells incorporating BUDR was determined in the prog-
eny of cells that had incorporated 3H thymidine at day 4 (A), and
in cells that had not incorporated 3H thymidine at day 4 (B).
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the cAMP-dependent mitogenic pathway. In the first possibil-
ity, it is expected that the inhibition of the cAMP-dependent
mitogenesis in cells having replicated DNA in the presence
of EGF (thymidine-labeled cells) would be dominant upon
fusion with a competent cell for cAMP-dependent mitogene-
sis (i.e., a cell from the same culture dish that had not incor-
porated thymidine in response to EGF) . In the second hy-
pothesis, the sensitivity to the cAMP-dependent mitogenic
stimulation wouldbe restored in the dikaryons resulting from
a fusion with a cAMP-dependent growth competent cell.
Thyroid cells were stimulated by EGF in the presence of 3H
thymidine, and then maintained for 2 d in control medium
to allow full expression ofthe inhibition ofthe CAMP-depen-
dent mitogenic stimulation. They were detached by trypsin,
fused by polyethyleneglycol treatment, andthe DNA replica-
tion activity (incorporation of BUDR) was studied in dikary-
ons after stimulation by TSH or EGR Autoradiography was
performed to identify the informative dikaryons, i .e., those
with only one thymidine-labeled nucleus.
In almost all dikaryons (99%), both nuclei behaved simi-
larly, i.e., both incorporated BUDR or not. As shown in Ta-
ble I A, homodikaryons containing two thymidine-labeled
nuclei or two thymidine-unlabeled nuclei responded as un-
fused cells labeled or not with thymidine. Some thymidine-
unlabeled homodikaryons replicated DNA in response to ei-
ther TSH or EGF, while thymidine-labeled homodikaryons
were insensitive to the mitogenic action of TSH. Heter-
odikaryons with only one thymidine-labeled nucleus be-
haved exactly as thymidine-labeled homodikaryons. They
still responded to EGF, but the mitogenic response to TSH
was abolished. Thus,the suppression ofthe mitogenic stimu-
lation by cAMP and TSH behaves as a dominant factor. As
a control, the same experiment was performed with cells
stimulated by TSH in the presence of 3H thymidine (Table I
B). In that case, a mitogenic response to either EGF or TSH
was retained in each sort ofdikaryons. Altogether, the results
suggestthat thereis acommitment duringCAMP-independent
cell cycle progression for the delayed induction ofa diffusible
factor that specifically represses the CAMP-dependent mito-
genic pathway.
Noteworthy, the partial homologous desensitizations (as
shown in Figs. 4 and 5) of EGF (Table I A) or TSH (Table
IB) growth responses also were dominant inheterodikaryons
with only one thymidine-labeled nucleus.
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Table I. DNA Synthesis in Dikaryons of Thyrocytes
A
B
Cells were cultured for 3 d in the presence of EGF (25 ng/ml) (A) or TSH
(1 mU/ml) (B), with 'H thymidine for the last 24 h. After rinsing, the cells
were cultured for two additional days in control medium, detached from the
dishes, fused with polyethyleneglycol, and seeded incontrol medium. Oneday
after, fused cells were stimulated for 40 h as indicated with BUDR for the last
24 h. For each treatment, BUDR incorporation was analyzed in each sort of
dikaryons (with two thymidine-labeled nuclei, »; two thymidine-unlabeled
nuclei, 00; or one thymidine-labeled nucleus, 0O) by counting a total of
-300 dikaryons. Values inAare the mean t SDofresults from three indepen-
dent experiments.
Discussion
390
The present results show that the great majority of dog thy-
roid cells in primary culture have initially the capacity to
proliferate in response to either TSH or EGF However, the
mitogenic response of the whole population is spread over
a considerable time. The apparent heterogeneity in the cell
sensitivity to mitogens, as it is observed at one time point,
is not due to the coexistence of different subpopulations with
different hereditary growth propensities. The latter hypoth-
esis was based on the demonstration in histological sections
ofclustered patterns ofheterogeneous cell responses (Studer
et al., 1989) and on the situation found in the immortal but
unstable FRTL-5 thyroid cell line in which each cell seems
endowed with its own growth pattern and degree of TSH de-
pendency which are inherited in the majority of its progeny
(Huber et al., 1990). In sharp contrast, using primary cul-
tures of thyroid cells with a limited division potential that
couldcorrespondto a finite life span invivo, we observe here
that the progeny ofcells that have proliferated at a given pe-
riod have a rather lower probability to divide at a second
period than cells that have remained quiescent during the
first period. Thus in the case of stimulation by either TSH
(even at low concentrations) or EGF, cells that divide at day
4 may notdivide at day 8 and vice versa, which demonstrates
that the heterogeneity of growth observed at one given mo-
ment is not constant in time. This has been similarly shown
for thyroid function in mice, since follicles that are not trap-
ping iodide at a given time have the same iodide content as
highly iodide trapping follicles (Mestdagh et al., 1990).
Why some cells do proliferate at the beginning of the cul-
ture and others several days lateris unclear. As also reported
by Derwahl et al. (1990) in FRTL-5 cells, dog thyroid cells
that divide at a given time are not randomly scattered in the
monolayer. As best observed in the case of stimulations with
suboptimal TSH concentrations, proliferating cells are fre-
quently gathered in large clusters. Cell clusters that had
proliferated at the beginning ofthe culture oftenpoorly over-
lap cell clusters proliferating a few days later. This indicates
a local synchrony of proliferating cells, which implies a com-
munication between neighboring cells, through diffusion of
BURR-labeled dikaryons
00 w
%
0.
Control 4.7 t 3 .3 0.9 f 0.7 1.7 f 2.5
EGF (25 ng/ml) 33.1 t 6.4 15.5 t 3.0 13.4 f 6.9
TSH (1 mU/ml) 21.0 t 5.3 1.3 t 0.3 1.0 t 0.8
Control 9.7 2.6 0.0
EGF (25 ng/ml) 32.1 12.4 28 .6
TSH (1 mU/ml) 38.7 12.2 16.7locally produced sutocrine factors, or through gapjunctions
that exist in thyroid cells(Munari-Silem et al., 1990). There-
fore,clustered distribution of cellsexhibiting similar proper-
ties, as observed in histological sections in thyroid gland,
may reflect local cell communication (Yap et al., 1987;
Munari-Silem et al., 1990). It does not necessarily imply
that these cells are members of a same progeny with special
inherited properties (as argued by Studer et al., 1989).
GenerationofStable Heterogeneity
The heterogeneity of growth responses described above ap-
pears essentially to result from temporary characteristics of
individual cells or groups of cells. However, this "dynamic"
heterogeneity can produce a qualitative change in the rvito-
gen responsiveness, thus, generating a more stable heteroge-
neity with two clearly distinct subpopulations. The progeny
of the fraction of cells having proliferated in control condi-
tions or during a limited treatment with EGF or serum retain
a reduced but marked responsiveness to EGF, but these cells
lose the mitogenic sensitivity to TSH and forskolin. The lat-
ter phenomenon differs from the inhibitory effects of EGF
on functional differentiation, which are reversible and inde-
pendent of cell cycle progression (Roger et al., 1985 ; Pohl
et al., 1990). As summarized in TableII, it is specific in mul-
tiple respects. (a) The fraction of cells that have not repli-
cated DNA during the limited EGF mitogenic treatment are
not affected in their responsiveness to TSH, which thus
generates two subpopulations qualitatively differing in their
growth responsiveness to TSH and CAMP. (b) Other re-
sponses to TSH and cAMP such as cytokeratin redistribution
(Fig. 6; Coclet et al., 1991) and thyroglobulin mRNA ex-
pression (Pohl et al., 1990) are not affected in cells having
proliferated with EGF, which indicates that the TSH/cAMP/
protein kinase A cascade is not grossly altered. (c) The
cAMP-dependent but not the EGF mitogenic stimulation is
abolished; and (d) the TSH/cAMP mitogenic response is re-
duced but not abolished in cellsthat have divided in response
to TSH . Further characterization, including analysis of het-
erodikaryons formed by fusion of thymidine-labeled and un-
labeled cells, suggests that the suppression of the cAMP-
dependent mitogenic pathway is due to the delayed induction
ofa dominant inhibitory factor(s). To our knowledge, a simi-
lar phenomenon has not yet been described in the growth
control ofother systems. It has several implications and war-
rants parallels with other epigenetic processes such as differ-
entiation and senescence.
Implicationsfor the Twopathways Hypothesis of
Growth Control
Our previous studies have indicated that the cAMP-
dependent mitogenic pathway (TSH) and the rapidly con-
verging cAMP-independent ones (EGF, phorbol esters, and
serum) remain partly separated until late commitment of
DNA synthesis (Roger et al., 1986, 1987a,ó; Maenhaut et
al., 1991). Differences include divergent patterns of protein
phosphorylations and thus utilization of different protein ki-
nases (Contor et al., 1988), partly divergent expression of
protooncogenes (Reuse et al., 1990, 1991), and synthesis of
different proteins during Gl phase (Lamy et al., 1989). Not
only the cell signalling cascade, but even the biochemical na-
ture ofthe Gl phase might be specific to the mitogenic stimu-
lus (Dumont et al., 1989). The TSH controlled cAMP-
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Table H. Summary of Observations
* Pohl et al. (1990).
mediated growth pathway may appear as an adjunctive
differentiated trait. Its unique characteristics might explain
how itcan be compatible with induction ofdifferentiation ex-
pression (Pohl et al., 1990; Reuse et al., 1990; Maenhaut et
al., 1991). The present data demonstrate directly that the
EGF tyrosine protein kinase and the cAMP mitogenic path-
ways coexist in parallel in the same cells. The responsiveness
of proliferation to either TSH or EGF is spread over the
majority of the cell population. Cells that have divided with
TSH can subsequently divide with EGF and vice versa (in
the EGF then TSH sequence, this is restricted to the lag be-
fore suppression of the CAMP-dependent growth pathway).
The fact that the cAMP-dependent mitogenic pathway was
inhibited, but much less the EGF-stimulated one, constitutes
an additional difference between the pathways. Also in rat
thyroid in vivo, an irreversible desensitization mechanism
specifically affects the TSH-dependent proliferation, but not
the proliferation induced by tissue wounding (Wynford-
Thomas et al., 1983; Smith et al., 1987). The nature and tar-
get of the inhibitory factor(s) remain to be determined. Our
fusion experiments suggest it should be a diffusible intracel-
lular factor that is stable or continuously produced. It should
interact with event(s) that are rate limiting in the cAMP-
dependent mitogenic pathway but not in the cAMP-indepen-
dent one, with no overall alteration of the cAMP/protein ki-
nase A cascade. The concept of such intracellular negative
regulators of cell cycle progression has been derived from
the analysis of heterokaryons of dividing and nondividing
cells (Stein and Yanishevsky, 1981; Adlakha et al., 1983; re-
viewed by Zelenin and Prudovsky, 1989) and more recently
from the identification oftumor suppressor genes(for reviews
see Harris, 1990; Levine and Mormand, 1990; Weinberg,
1990). However, the proposed factors have not been shown
to specifically inhibit one particular mitogenic pathway.
Another new dimension ofthe two mitogenic pathways hy-
pothesis is provided by the observation that the suppression
of the cAMP-dependent growth pathway is induced during
cell cycle performance in response to cAMP-independent
factors (EGF, 10% serum or even with 1% serum + insulin
[control conditions]), but not during the TSH-stimulated
cAMP-dependent cell cycling. This implies that the cAMP-
dependent and independent cell cycles are not equivalent in
termsofthe maintenance ofone important feature of the thy-
roid phenotype.
Parallels with Differentiation andSenescence
The concept oftwo kinds of cell cycle-either preserving or
39 1
Mitogenic Morphology/
response differentiation*
(BUDR) responses
Mitogenic Thymidine (days 6-8) (days 6-8)
treatment incorporation
(days 1-4) at day 4 EGF TSH/forskolin TSH/forskolin
Control/EGF/
FCS (10%) Yes + - ++
No ++ ++ ++
TSH/forskolin Yes + + + +
No ++ ++ ++changing differentiation phenotypes-is well admitted in
various models of cell differentiation (Lajtha, 1979; Ya-
mada, 1989). Moreover, differentiation processes generally
include modifications of growth characteristics. As pointed
out above, the TSH/cAMP-dependent mitogenic pathway,
which is repressed in cell fusion experiments, could be ana-
lyzed as a differentiated trait of thyrocytes. The TSH/cAMP
growth pathway is specifically lost in somatic hybrids of
FRTL-5 thyroid cells and BRL rat liver cells (Veneziani et
al ., 1990), or in hybrids of FRTL-5 and undifferentiated FRT
thyroid cells (Zurzolo et al ., 1991). Differentiated functions
are also generally suppressed in heterokaryons or somatic
hybrids formed by the fusion of a cell expressing this func-
tion with a nonexpressing cell (Harris, 1990). In some cases,
it has been demonstrated that the extinction is due to a trans-
dominant inhibitory gene locus which is normally expressed
in the cell that does not express the differentiated function
(Killary and Fournier, 1984; Chinand Fournier, 1987; Boshart
et al., 1990; Thayer and Weintraub, 1990).
In the present case, the trans-dominant activity that sup-
presses the cAMP-dependent mitogenic pathway is not ini-
tially present in differentiated thyrocytes. Paradoxically, in
several respects its appearance also resembles a differen-
tiated process. As adipose conversion of fibroblasts, for in-
stance (Kuri-Harcuch and Marsch-Moreno, 1983), it is a
stable but delayed phenomenon, the induction of which re-
quires the performance of one mitotic cell cycle. Its in-
heritance after further division is unfortunately not testable,
since likely it would be restored at each cAMP-independent
division.
The suppression of cAMP-dependent mitogenic pathway
after division of dog thyrocytes induced by cAMP-indepen-
dent factors also resembles a senescence process. Cellular
senescence involves irreversible changes in proliferation ca-
pacity and mitogen responsiveness occurring during succes-
sive cell cycles, which lead to a gradualincrease in the hetero-
geneity of individual growth responses (Bell et al., 1978;
Smith and Whitney, 1980; Brooks and Riddle, 19886), until
complete cessation of proliferation. The finite life span phe-
notype is also dominant and senescent humanfibroblasts ex-
press one or more dominant inhibitors of proliferation (Stein
and Yanishevsky, 1981; Pereira-Smith and Smith, 1988).
The quite abrupt extinction of the cAMP-dependent prolif-
eration might thus be considered as some kind ofconditional
(heterologous) pathway-specific senescence. It should be dis-
tinguished from the more progressive and relative reduction
of mitogen responsiveness observed in dog thyrocytes con-
tinuously stimulated with TSH or EGF, which is also domi-
nant in cell fusion experiments, but probably reflects the very
limited division potential of these cells (Fig. 1; Coclet et al.,
1989).
Implicationsfor Thyroid Goitrogenesis
The goiter, which results from thyroid hyperplasia, is diffuse
in a first stage, but becomes heterogeneous, then multinodu-
lar later. Although its initial goitrogenic causemay be unique
(congenital defect, goitrogen, iodide lack), it is character-
ized by a very important regional heterogeneity of function
and growth ofthyroid epithelialcells. The causeofthis heter-
ogeneity is much debated (Peter et al., 1985; Studer et al.,
1989; Many et al., 1986; Denef et al., 1989) . It might de-
pend on environmental factors, or on intrinsic properties of
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follicular thyroid cells. The nodules in a multinodular goiter
are polyclonal (Namba et al ., 1990) unlike the solitary nod-
ules which represent true adenomas (Thomas et al ., 1989;
Namba et al., 1990) . Therefore, they do not result as sug-
gested (Peter et al ., 1985 ; Studer et al., 1989) from an am-
plification during growth of genetically different subpopula-
tions. Here, we have shown that heterogeneity may arise
from the competition between two different modes ofcell cy-
cle progression, either preserving or transforming growth
responses to external endocrine (e.g., TSH) or paracrine
(e.g., EGF) factors. Since these responses seem to occur in
clusters of communicating cells, this could explain the re-
gional, patchy pattern of the resulting stable heterogeneity,
as it is observed in multinodular goiter.
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